Narcotic vs. Non-narcotic Pain Study Protocol

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

347 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2022-02-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purposes of this noninferiority randomized clinical trial are to:

1. determine whether the most commonly used commonly used non-narcotic analgesic (ibuprofen 600 mg + acetaminophen 325 mg) provides pain relief that is not unacceptably worse than the most commonly prescribed narcotic containing analgesic (hydrocodone 5 mg. + acetaminophen 325 mg, equivalent to Norco 5/325) in patients undergoing carpal tunnel release.
2. Determine whether the following covariates affect pain level following surgery or medication usage: gender, country (US/Canada), pre-operative CTS symptoms, site, workers compensation status and employment status (employed/self-employed/unemployed-able to work/unemployed-unable to work)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Narcotic Versus Non-narcotic Medication for Pain Management After Wrist/Hand Fractures

NCT03375593

Distal Radius Fracture Pain Management Metacarpal Fracture

UNKNOWN PHASE4

Opioid Free Management After Ureteroscopy

NCT03872843

Kidney Stone

COMPLETED PHASE4

Postoperative Pain Control in Septum and Sinus Surgery

NCT04149964

Post-operative Pain Sinus Surgery

COMPLETED PHASE4

Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects

NCT01924182

Chronic Pain

TERMINATED NA

An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back Pain

NCT01843660

Low Back Pain Shoulder Pain Neck Pain

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be provided with forms by site coordinators and will be provided in person instruction on how to fill out the pain intensity scores, the pain interference scores, the pain medication diary, and the final pain relief assessment form.

Medications will be identified only by number and will be available to the participant after standard instruction on use of medications is provided by the surgeon or research associate. Patients will be instructed - verbally and written - to take the study medication (2 capsules per dose) up to four times per day as needed for pain for 1 week or until pain free.

If patients experience intolerable discomfort, they will be able to contact personnel (24 hours on call) associated with the study to receive an alternate analgesic. The surgeon will determine if the patient is taking the maximum dose and then prescribe additional study drug or a non-study drug as an alternative. If the patient receives pain medication outside of the study protocol, the medication will be recorded, this will be recorded as a protocol violation. If this occurs in more than 20 people during the trial a per-protocol and efficacy analysis will be considered.

Participants will return to see the surgeon or designate between post-operative day 7 and 14 to return their diary, unused medication, and post-operative pain satisfaction survey. Participants will be specifically asked about: any adverse events, compliance with the program and the reason for any deviation and any other analgesic medication taken during the course of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Narcotic

Hydrocodone + acetaminophen 4 times per day 1 week after surgery

Group Type EXPERIMENTAL

Narcotic

Intervention Type DRUG

Hydrocodone 5mg + acetaminophen 325 mg

non-narcotic

ibuprofen + acetaminophen 4 times per day 1 week after surgery

Group Type ACTIVE_COMPARATOR

non-narcotic

Intervention Type DRUG

ibuprofen 600mg + acetaminophen 325 mg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Narcotic

Hydrocodone 5mg + acetaminophen 325 mg

Intervention Type DRUG

non-narcotic

ibuprofen 600mg + acetaminophen 325 mg

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Hydrocodone/acetaminophen ibuprofen + acetaminophen

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients undergoing elective a primary carpal tunnel release will be considered eligible

Exclusion Criteria

* Patients wil be excluded for any of the following:
* previously enrolled in this study (for carpal tunnel surgery on the other hand);
* history of chronic opioid use;
* documented or suspected substance abuse;
* individuals currently on daily use of ibuprofen, acetaminophen or other pain altering medication including medications like Neurontin (gabapentin) and Ultram (tramadol)
* individuals with documented or suspected chronic pain syndrome;
* reported allergy or adverse reaction to hydrocodone, acetaminophen, or ibuprofen;
* those with a history or symptoms of any significant medical problem in the last year (i.e., arrhythmia, impaired cardiovascular function, gastrointestinal bleeding, liver disease, renal disease);
* patients with active peptic ulcer disease (history of severe heartburn);
* symptoms of infection with initial enrollment;
* pregnant or lactating women;
* those with a diagnosis of cognitive impairment;
* patients unable or unwilling to provide informed consent for surgery or enrollment in a clinical trial;
* patients unable or unwilling to fill out the forms or understand the consent form
* prior carpal tunnel surgery on the hand to be operated on
* individuals currently taking Coumadin, Plavix, or medications that increase bleeding; or
* patients with other medical or psychological health conditions that preclude then from receiving either intervention or returning for follow-up visits

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No